Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Cancer Survivorship
Published in: Journal of Cancer Survivorship 3/2014

01-09-2014

Coexistence of urinary incontinence and major depressive disorder with health-related quality of life in older Americans with and without cancer

Authors: Alexandra J. White, Bryce B. Reeve, Ronald C. Chen, Angela M. Stover, Debra E. Irwin

Published in: Journal of Cancer Survivorship | Issue 3/2014

Login to get access

Abstract

Purpose

This study evaluates the prevalence and factors associated with major depressive disorder (MDD) in a population of cancer survivors and the impact of co-occurring MDD and urinary incontinence (UI) on health-related quality of life (HRQOL).

Methods

The prevalence of MDD risk among cancer survivors (breast, prostate, bladder, colorectal, lung, and endometrial/uterine cancers) and those without cancer was estimated using the Surveillance, Epidemiology and End Results Program-Medicare Health Outcomes Survey (SEER-MHOS) linked database (n = 9,282 with cancer/n = 289,744 without cancer). Risk for MDD was measured using three items from the Diagnostic Interview Schedule, and HRQOL was measured by the SF-36. UI was defined as self-reported leakage of urine causing a problem in previous 6 months. Factors associated with MDD were investigated using logistic regression, and the impact of co-occurring MDD and UI on HRQOL scores was determined using linear regression.

Results

The prevalence of MDD risk ranged from 19.2 % for prostate to 34.1 % for lung. Lung cancer diagnosis was associated with risk of MDD. Being ≥5 years from diagnosis was associated with decreased risk of MDD (prevalence odds ratio (POR) = 0.82, 95 % confidence interval (95 % CI) 0.71, 0.95). The coexistence of both UI and MDD was associated with a decrease across HRQOL subscales; including 40 points on role-emotional (RE) score.

Conclusions

Cancer survivors reporting co-occurrence of UI and MDD experienced significant decrements in HRQOL.

Implications of Cancer Survivors

Understanding the combined effect of UI and MDD may help clinicians to better recognize and alleviate their effects on cancer survivors’ HRQOL.
Literature
1.
2.
3.
4.
Siegel R et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012;62(4):220–41.CrossRefPubMed
5.
Bellizzi KM, Rowland J. The role of comorbidity, symptoms and age in the health of older survivors following treatment for cancer. Aging Health. 2007;3:625635.CrossRef
6.
Rao AV, Demark-Wahnefried W. The older cancer survivor. Crit Rev Oncol Hematol. 2006;60(2):131–43.CrossRefPubMed
7.
8.
Kessler RC et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289(23):3095–105.CrossRefPubMed
9.
Serby M, Yu M. Overview: depression in the elderly. Mt Sinai J Med. 2003;70(1):38–44.PubMed
10.
Pirl WF. Evidence report on the occurrence, assessment, and treatment of depression in cancer patients. J Natl Cancer Inst Monogr. 2004;32:32–9.CrossRefPubMed
11.
12.
Anger JT et al. The prevalence of urinary incontinence among community dwelling men: results from the National Health and Nutrition Examination Survey. J Urol. 2006;176(5):2103–8. Discussion 2108.CrossRefPubMed
13.
Anger JT et al. The prevalence of urinary incontinence among community dwelling adult women: results from the National Health and Nutrition Examination Survey. J Urol. 2006;175(2):601–4.CrossRefPubMed
14.
15.
Coyne KS et al. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study. BJU Int. 2008;101(11):1388–95.CrossRefPubMed
16.
Girman CJ et al. Health-related quality of life associated with lower urinary tract symptoms in four countries. Urology. 1998;51(3):428–36.CrossRefPubMed
17.
O’Donnell M et al. Help-seeking behaviour and associated factors among women with urinary incontinence in France, Germany, Spain and the United Kingdom. Eur Urol. 2005;47(3):385–92. Discussion 392.CrossRefPubMed
18.
Rosen RC, Giuliano F, Carson CC. Sexual dysfunction and lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). Eur Urol. 2005;47(6):824–37.CrossRefPubMed
19.
Kwong PW et al. Urinary incontinence and quality of life among older community-dwelling Australian men: the CHAMP study. Age Ageing. 2010;39(3):349–54.CrossRefPubMed
20.
Manchana T. Long-term lower urinary tract dysfunction in gynecologic cancer survivors. Asian Pac J Cancer Prev APJCP. 2011;12(1):285–8.PubMed
21.
Parsons BA, Evans S, Wright MP. Prostate cancer and urinary incontinence. Maturitas. 2009;63(4):323–8.CrossRefPubMed
22.
Porter MP, Penson DF. Health related quality of life after radical cystectomy and urinary diversion for bladder cancer: a systematic review and critical analysis of the literature. J Urol. 2005;173(4):1318–22.CrossRefPubMed
23.
Reeve BB et al. Impact of diagnosis and treatment of clinically localized prostate cancer on health-related quality of life for older Americans: a population-based study. Cancer. 2012;188(22):5679–87.CrossRef
24.
White AJ et al. Urinary incontinence and health-related quality of life among older Americans with and without cancer: a cross-sectional study. BMC Cancer. 2013;13:377.PubMedCentralCrossRefPubMed
25.
Non-surgical treatments for urinary incontinence in adult women: diagnosis and comparative effectiveness comparative effectiveness review Summary Guides for Clinicians. 2007, Rockville MD.
26.
Collado Serra A et al. AdVance/AdVance XP transobturator male slings: preoperative degree of incontinence as predictor of surgical outcome. Urology. 2013;81(5):1034–9.CrossRefPubMed
27.
Plotti F et al. Urinary incontinence after radical vulvectomy treated with Macroplastique implantation. J Minim Invasive Gynecol. 2008;15(1):113–5.CrossRefPubMed
28.
Plotti F et al. Post radical hysterectomy urinary incontinence: a prospective study of transurethral bulking agents injection. Gynecol Oncol. 2009;112(1):90–4.CrossRefPubMed
29.
30.
Ambs A et al. Overview of the SEER–Medicare Health Outcomes Survey linked dataset. Health Care Financ Rev. 2008;29(4):5–21.PubMedCentralPubMed
31.
32.
Rost K, Burnam MA, Smith GR. Development of screeners for depressive disorders and substance disorder history. Med Care. 1993;31(3):189–200.CrossRefPubMed
33.
34.
Fleishman JA, Selim AJ, Kazis LE. Deriving SF-12v2 physical and mental health summary scores: a comparison of different scoring algorithms. Qual Life Res. 2010;19(2):231–41.CrossRefPubMed
35.
36.
Jones 3rd N, Jones SL, Miller NA. The Medicare Health Outcomes Survey program: overview, context, and near-term prospects. Health Qual Life Outcomes. 2004;2:33.PubMedCentralCrossRefPubMed
37.
Hays RD, Farivar SS, Liu H. Approaches and recommendations for estimating minimally important differences for health-related quality of life measures. COPD. 2005;2(1):63–7.CrossRefPubMed
38.
Felde G, Bjelland I, Hunskaar S. Anxiety and depression associated with incontinence in middle-aged women: a large Norwegian cross-sectional study. Int Urogynecol J. 2012;23(3):299–306.CrossRefPubMed
39.
Sims J et al. Urinary incontinence in a community sample of older adults: prevalence and impact on quality of life. Disabil Rehabil. 2011;33(15–16):1389–98.CrossRefPubMed
40.
Wyrwich KW et al. A comparison of clinically important differences in health-related quality of life for patients with chronic lung disease, asthma, or heart disease. Health Serv Res. 2005;40(2):577–91.PubMedCentralCrossRefPubMed
41.
Kosinski M et al. Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis. Arthritis Rheum. 2000;43(7):1478–87.CrossRefPubMed
42.
43.
Bell JR. Underdiagnosis of depression in primary care: by accident or design? JAMA. 1997;277(18):1433.CrossRefPubMed
44.
Hakkinen JT et al. Depressive symptoms increase the incidence of nocturia: Tampere Aging Male Urologic Study (TAMUS). J Urol. 2008;179(5):1897–901.CrossRefPubMed
45.
Tannenbaum C et al. Comorbidities associated with bladder dysfunction. Int J Clin Pract. 2013;67(2):105–13.CrossRefPubMed
46.
Avis NE et al. Age-related longitudinal changes in depressive symptoms following breast cancer diagnosis and treatment. Breast Cancer Res Treat. 2013;139(1):199–206.CrossRefPubMed
47.
Giese-Davis J et al. Decrease in depression symptoms is associated with longer survival in patients with metastatic breast cancer: a secondary analysis. J Clin Oncol. 2011;29(4):413–20.PubMedCentralCrossRefPubMed
48.
Bennett JA et al. Time since diagnosis as a predictor of symptoms, depression, cognition, social concerns, perceived benefits, and overall health in cancer survivors. Oncol Nurs Forum. 2010;37(3):331–8.CrossRefPubMed
49.
Pirl WF et al. Major depressive disorder in long-term cancer survivors: analysis of the National Comorbidity Survey Replication. J Clin Oncol. 2009;27(25):4130–4.PubMedCentralCrossRefPubMed
50.
Palsson SP, Ostling S, Skoog I. The incidence of first-onset depression in a population followed from the age of 70 to 85. Psychol Med. 2001;31(7):1159–68.PubMed
51.
Roberts RE et al. Does growing old increase the risk for depression? Am J Psychiatry. 1997;154(10):1384–90.CrossRefPubMed
52.
Forsell Y, Winblad B. Incidence of major depression in a very elderly population. Int J Geriatr Psychiatry. 1999;14(5):368–72.CrossRefPubMed
53.
Djernes JK. Prevalence and predictors of depression in populations of elderly: a review. Acta Psychiatr Scand. 2006;113(5):372–87.CrossRefPubMed
54.
Gyhagen M et al. The prevalence of urinary incontinence 20 years after childbirth: a national cohort study in singleton primiparae after vaginal or caesarean delivery. BJOG Int J Obstet Gynaecol. 2012.
55.
Bodhare TN, Valsangkar S, Bele SD. An epidemiological study of urinary incontinence and its impact on quality of life among women aged 35 years and above in a rural area. Indian J Urol. 2010;26(3):353–8.PubMedCentralCrossRefPubMed
56.
57.
Johansson M, Ryden A, Finizia C. Mental adjustment to cancer and its relation to anxiety, depression, HRQL and survival in patients with laryngeal cancer—a longitudinal study. BMC Cancer. 2011;11:283.PubMedCentralCrossRefPubMed
58.
Jorngarden A, Mattsson E, von Essen L. Health-related quality of life, anxiety and depression among adolescents and young adults with cancer: a prospective longitudinal study. Eur J Cancer. 2007;43(13):1952–8.CrossRefPubMed
Metadata
Title
Coexistence of urinary incontinence and major depressive disorder with health-related quality of life in older Americans with and without cancer
Authors
Alexandra J. White
Bryce B. Reeve
Ronald C. Chen
Angela M. Stover
Debra E. Irwin
Publication date
01-09-2014
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 3/2014
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-014-0360-8

Other articles of this Issue 3/2014

Journal of Cancer Survivorship 3/2014 Go to the issue

OriginalPaper

Determinants of newly diagnosed comorbidities among breast cancer survivors

OriginalPaper

Social Networking Site Usage among Childhood Cancer Survivors—A Potential Tool for Research Recruitment?

Review

Psychosocial factors in adjuvant hormone therapy for breast cancer: an emerging context for adherence research

OriginalPaper

Predictors of successful use of a web-based healthcare document storage and sharing system for pediatric cancer survivors: Cancer SurvivorLinkTM

OriginalPaper

Unmet information and support needs in newly diagnosed thyroid cancer: comparison of adolescents/young adults (AYA) and older patients

OriginalPaper

Male infertility in long-term survivors of pediatric cancer: a report from the childhood cancer survivor study
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits